Best match

Most recent

Bravo

Lead paragraph

Privately-held Dutch immune-mediated inflammatory diseases company Citryll is the latest stop for experienced biotech chief executive Eduardo Bravo. Mr Bravo has previously held the top job at Nordic Nanovector, TiGenix and Cellerix. During his time at ...

Eduardo Bravo and Tim Schenk take lead roles at Citryll

The Pharma Letter

Kingdom of the Netherlands

Development

Citryll, a clinical-stage biotech company developing therapeutics to treat immune-mediated inflammatory diseases, has appointed Eduardo Bravo as CEO and Tim Schenk as chief business officer. The appointments come at a time when the company has completed ...

The Netherlands: Citryll makes senior appointments as it moves to next stage of development

laingbuissonnews

Lupus erythematosus

Compound annual growth rate

Skin

The dynamics of the cutaneous lupus erythematosus market are anticipated to change in the coming years owing to the expected launch of emerging therapies. The rising research and prevalence, along ...

Cutaneous Lupus Erythematosus Market is Expected to Surge at a CAGR of 7.2% by 2032, Assesses DelveInsight

PR Newswire

Surge

Research

DelveInsight Business Research, LLP: Cutaneous Lupus Erythematosus Market is Expected to Surge at a CAGR of 7.2% by 2032, Assesses DelveInsight

Finanznachrichten

Yahoo Finance

Report Metrics Details Study Period 2019–2032 Coverage 7MM [The United States, the EU-4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan] and China Cutaneous Lupus ...

Benzinga.com

Bravo Brio Restaurant Group

OSS, the Netherlands--(BUSINESS WIRE)-- Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat immune-mediated inflammatory diseases, today announced the appointment of Eduardo Bravo as Chief Executive Officer.

Citryll Announces Appointments of Eduardo Bravo as CEO and Tim Schenk as CBO

BioSpace

Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat immune-mediated inflammatory diseases, today announced the appointment of Eduardo Bravo as Chief Executive ...

Get the most recent info and news about Citryll on HackerNoon, where 10k+ technologists publish stories for 4M+ monthly readers.

Citryll BV is a private pharmaceutical company based in Oss, the Netherlands that is dedicated to the development and commercialization of therapeutics that target NETosis and NETs. Target diseases include SLE, RA, vasculitis, cancer and fibrosis.

Citryll

citryll.com

20 employees

Since 2015

COMPANY RANKING

Citryll

EVERGREEN INDEX #1016

See more notable links about Citryll

Apply to get your Tech Company News Page live on HackerNoon.com today!

Read More Tech Stories Related to #Citryll

Citryll

Citryll

citryll.com

20 employees

Since 2015

COMPANY RANKING

Citryll

EVERGREEN INDEX #1016

Related CompaniesRank

Citryll Story MentionsComplete List

See more notable links about Citryll

Apply to get your Tech Company News Page live on HackerNoon.com today!

Read More Tech Stories Related to #Citryll

Citryll